optimum duration of treatment with osteoporosis medications?
- Oral bisphosphonates
- 5 years (low/moderate-risk patients)
- 6 to 10 years (high-risk patients aa High-risk patients: old age, prior fracture, very low BMD (T-score <–3), high fall risk, GC use.)
- Zoledronic acid
- 3 years (low/moderate-risk patients)
- 6 years (high-risk patients a )
- Denosumab: stopping not recommended without substituting another agent
- Teriparatide/Abaloparatide: 24 months followed by an antiresorptive agent
